Peripheral Arterial Disease Trial, Recruiting NCT06277362 Sponsor: EndoCore Lab s.r.l. Condition: Peripheral Arterial Disease
Back to Peripheral Arterial Disease

Peripheral Arterial Disease Trial, Recruiting

NCT06277362
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be 18 years of age or older
  • You must have signed an approved consent form agreeing to take part in the trial
  • You must have severe reduced blood flow to your lower limb(s) that cannot be treated by reopening the blood vessels, either because two previous attempts to open the vessels with a balloon procedure have failed, or because the arteries are too stiff/calcified or too small to treat
  • You must have a serious level of reduced blood flow to your leg(s) (classified as Rutherford category 5 or 6), meaning you have active wounds or tissue damage on your foot or leg
  • Your heart must be pumping at least 30% of its normal capacity (confirm with trial site)

Who may not be able to join:

  • People who are unable to attend follow-up appointments or whose circumstances would make regular check-ins during the trial difficult
  • People whose reduced blood flow to the lower limb(s) could still be treated using a bypass surgery or a balloon procedure to open the blood vessels, or whose main symptom is pain at rest without active wounds (classified as Rutherford category 4 or below)
  • People whose heart is pumping less than 30% of its normal capacity

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Gabriele Morselli, PharmD, EndocoCore Lab s.r.l.

Phone: +39 3499105666

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
EndoCore Lab s.r.l.
Registry
ClinicalTrials.gov
Start date
31 January 2020
Est. completion
1 December 2028

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Safety Composite

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov